Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AZRX Stock Forecast 2026-2027
$6.47
Current Price
$508.38M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to AZRX Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
AZRX Price Momentum
0.0%
1 Week Change
+89.2%
1 Month Change
+1,098.1%
1 Year Change
+38.8%
Year-to-Date Change
-6.6%
From 52W High of $6.93
+1,692.2%
From 52W Low of $0.36
📊 TOP ANALYST CALLS
Did AZRX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if AzurRx is one of their latest high-conviction picks.
Latest AZRX Stock Price Targets & Analyst Predictions
AZRX has shown a year-to-date change of 38.8% and a 1-year change of 1,098.1%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for AZRX. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AZRX Analyst Ratings
0
Buy
0
Hold
0
Sell
AZRX Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $6.47
Latest AZRX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AZRX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
AzurRx BioPharma Inc (AZRX) Competitors
The following stocks are similar to AzurRx based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
AzurRx BioPharma Inc (AZRX) Financial Data
Valuation Metrics
Market Cap
$508.38M
Enterprise Value
$502.95M
P/E Ratio
-0.5x
PEG Ratio
0.0x
Price/Sales
N/A
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
EPS Growth
N/A
Financial Health
Cash/Price Ratio
N/A
Current Ratio
0.4x
Debt/Equity
0.0x
ROE
+43.3%
ROA
-680.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
AzurRx BioPharma Inc (AZRX) Business Model
About AzurRx BioPharma Inc
What They Do
N/A
Business Model
N/A
Additional Information
N/A
Company Information
AzurRx BioPharma Inc (AZRX) Latest News & Analysis
Latest News
Quick Summary
The company will start trading on Nasdaq under the new ticker symbol "FBWI" effective September 22.
Why It Matters
The new ticker symbol “FBWI” indicates a change that may reflect strategic shifts or company rebranding, potentially impacting stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
AzurRx BioPharma Inc (NASDAQ: AZRX) will acquire First Wave Bio Inc for $229 million in stock and cash, focusing on therapies for autoimmune inflammatory bowel diseases.
Why It Matters
AzurRx's acquisition of First Wave Bio enhances its portfolio in the biotech sector, potentially boosting growth prospects and market position in treating autoimmune diseases.
Source: Benzinga
Market Sentiment:
Positive
Quick Summary
AzurRx BioPharma's CEO James Sapirstein discussed the acquisition of First Wave Bio during a conference call, detailing its impact on the company's strategy and growth.
Why It Matters
The acquisition may signal strategic growth and potential for AZRX, impacting its market position, future earnings, and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
AzurRx BioPharma will be renamed "First Wave BioPharma" and will begin trading on NASDAQ under the new ticker symbol "FWBI."
Why It Matters
The rebranding and ticker change signal a strategic shift for AzurRx BioPharma, potentially impacting investor perception and stock performance due to fresh market positioning.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
AzurRx BioPharma, now named First Wave BioPharma, announced a merger with First Wave Bio, as stated in a letter from CEO James Sapirstein to shareholders.
Why It Matters
The merger with First Wave Bio signifies a strategic shift for AzurRx BioPharma, potentially enhancing its market position and attracting investor interest in the biopharmaceutical sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
AzurRx BioPharma (AZRX) has acquired First Wave Bio for $229 million and will rename itself First Wave BioPharma post-acquisition.
Why It Matters
The acquisition signifies a strategic expansion for AzurRx, potentially enhancing its market position and product offerings, which could impact stock performance and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About AZRX Stock
What is AzurRx BioPharma Inc's (AZRX) stock forecast for 2026?
Analyst forecasts for AzurRx BioPharma Inc (AZRX) are not currently available. The stock is trading at $6.47.
Is AZRX stock a good investment in 2026?
Analyst ratings for AZRX are not currently available. The stock is currently trading at $6.47. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AZRX stock?
Price predictions from Wall Street analysts for AZRX are not currently available. The stock is trading at $6.47.
What is AzurRx BioPharma Inc's business model?
N/A
What is the highest forecasted price for AZRX AzurRx BioPharma Inc?
Price targets from Wall Street analysts for AZRX are not currently available. The stock is trading at $6.47.
What is the lowest forecasted price for AZRX AzurRx BioPharma Inc?
Price targets from Wall Street analysts for AZRX are not currently available. The stock is trading at $6.47.
What is the overall AZRX consensus from analysts for AzurRx BioPharma Inc?
Analyst ratings for AZRX are not currently available. The stock is trading at $6.47.
How accurate are AZRX stock price projections?
Stock price projections, including those for AzurRx BioPharma Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 9, 2026 10:30 AM UTC